INTRODUCTION
An ideal indwelling medical device would possess surfaces with the same properties as those inside the healthy human body, such as that of blood vessels. Surfaces of indwelling medical devices should be smooth, not only to allow healthy tissue cells to grow easily and resist bacterial adhesion, but also to destroy bacterial cells that come into contact with them. Therefore, strategies for manufacturing anti-infective devices should focus on developing the device surfaces that would not trigger the host defense system, that resist bacterial adhesion, and that promote the formation of a layer of living cells.
A smooth and uniform surface could be an important feature to resist bacterial adhesion. In a study on the bacterial adhesion on Dacron R fibers, it was reported that in a buffer solution containing human plasma protein, S. epidermidis adhered to the fiber surfaces (Wang et al., 1995) . A conclusion that may be drawn from this evidence is that even if a surface inhibits bacterial adherence, bacteria can still find space to survive if the surface is rough enough.
Healthy integrated tissues are resistant to infections because the formation of a close, healthy homeostatic tissue integration provides a barrier against invading bacteria. Surface physiochemical properties of indwelling medical devices play an important role in the interfacial behavior of devices in contact with body fluids and tissues. If a medical device surface is designed and manufactured to favor integration by tissue cells, upon placing the device in a living body, the surface may either directly integrate with healthy tissue cells via chemical bonding or separate by an intervening layer of matrix proteins. This permits the surface to become inert to the body homeostasis as well as resistant to bacterial adherence.
Surface modification of the existing device is a relatively straight-forward strategy for creating Hydrogels are a class of hydrophilic polymers that can absorb water up to several times their own weight without dissolving. Hydrogel polymers are much softer after water absorption, providing a softer surface for tissue contact and, therefore, possibly reducing the stimulation of a foreign surface to living tissues and possibly increasing the biocompatibility of the medical device surface. In addition most microorganisms reduced adhesion on hydrogel-coated surfaces because of increased hydrophilicity (Brisset et al., 1996 , Hogt et al., 1983 , and 1986 ). Polyvinylpyrrolidone and polyethylene glycol are typical examples of hydrogel polymers that have been used in indwelling medical device surface modifications. Hydrophilic polymer film formed by UV crosslinking derivatives of polyvinylpyrrolidone showed the reduction of bacterial adhesion in vitro on materials used to construct urinary catheters (Duran et al., 1995) . A study on the bacterial attachment to a self-assembled monolayer of oligo (ethylene glycol) found that the surface resists the attachment of D. mariva and S. epidermidis (Ista et al., 1996) . Bridgett et al studied in vitro bacterial adherence of S. epidermidis on polystyrene surfaces modified by A-B-A copolymers, where A is poly (ethylene oxide) (PEO) and B is poly (propylene oxide) (PPO), and found substantial reductions in bacterial adhesion, up to 97 %, with all copolymers tested, and the reduction was independent of the PEO and PPO block length and copolymer molecular weight (Bridgett et al., 1992) . The author suspects that copolymers absorb to the hydrophobic polystyrene via their hydrophobic PPO blocks, and the protruding hydrophilic PEO blocks may form a steric barrier to bacterial adhesion.
In a single-blind randomized clinical study, Bull et al compared the performance of a hydrogel-coated and a silicone-coated urinary catheter in 69 patients. They reported that the hydrogel catheters remained in place longer than those which were silicone-coated and caused less urine leakage problems. Eleven hydrogel-coated and nine silicone-coated catheters had to be changed because of encrustation during 16 weeks of the catheterization period (Bull et al., 1991).
2. Modification of medical device surface by using anti-infective agents Studies reveal that although surface properties such as surface energy, wettability, and uniformity, significantly influence the ability of bacteria to adhere to a medical device, changing bacterial strains and the physiological media with which the device is in contact will also alter the adhesion process. Modifying device surfaces to become more hydrophilic may reduce the adherence of some bacterial strains, but may also increase the adherence of some other strains (Hogt et al., 1983) . No surface has been proven resistant to all important bacteria that cause device-related infections.
Incorporating non-toxic anti-infective agents, such as antimicrobials, antibiotics, and other pharmaceutical agents that kill bacteria, on the device surface would provide an alternate approach to assure a surface free of bacteria. Surface treatments to incorporate anti-infective agents onto the surfaces of medical devices have significant advantages. They can incorporate a large variety of anti-infective agents on the surface and modify the existing devices easily and inexpensively without changing the bulk properties of the device. Coatings with anti-infective agents have shown promising results and appear to increase biocompatibility and resist the adhesion of the bacteria on surfaces of indwelling medical devices (Pearson and Abrutyn, 1997) .
Anti-infective agents that kill microorganisms can provide devices with a chemical barrier against the intruding organisms. Device surfaces with such agents can provide a high concentration of anti-infective agents in a local environment, disinfecting bacteria that enter together with the medical device or that encounter the device later through any other route before they have a chance to generate a biofilm to protect themselves.
The current surface-treatment technologies incorporating anti-infective agents can be classified into three categories and will discussed followings: the deposition of a thin film of anti-infective agents on the surface, the ionic bonding of anti-infective agents, and the entrapment of anti-infective agents in a polymer matrix.
2-1. Direct deposition method
The direct deposition method applies pure antiinfective agents directly onto a medical device surface. Silver and its compounds, as well as other antimicrobials, applied on a device surface by this method, have shown reductions of bacterial adherence. The effectiveness of the silver ion as an antibacterial agent has long been known. Silver and its cornpounds have broad-spectrum antimicrobial activity and low toxicity to the human body. Recently, technologies have developed the use of silver and its compounds as anti-infective agents in reducing device-related infections after promising reports have shown that in vitro silver coatings prevent the adherence and growth of Escherichia coil and Pseudomonas aeruginosa without causing cell toxicity (Liedberg and Lundeberg, 1989) .
Silver coatings were found to be effective in reducing the chances of infection caused by medical devices implanted or inserted into the body. A few small clinical trials of silver-coated urinary catheters in selected patients have found marked reductions in catheter-related bacteriuria (Lundeberg, 1986) . In a randomized clinical study, silver alloy deposited on foley catheters significantly reduced the incidence of catheter-related bacteriuria in comparison with Teflonized catheters after six days of catheterization. Ten % of the patients with silver-coated catheters developed bacteriuria compared with 37% of the patients who had the Teflonized latex catheters. The silver-impregnated foley catheters showed promising results in reducing the incidence of catheterassociated urinary tract infection (Liedberg and Lundeberg, 1990) .
Application of silver metal on the surface of orthopedic external fixation pins by ion beam assistant deposition was utilized to prevent pin tract infections, which were reported to have infection rates up to 40 percent (Ostermann et al., 1994) . The silver film formed by this technology is minimally leachable and kills bacteria when they come into contact with it. In vitro colonization results indicate that the silver filmcoated pins reduced the number of the colonies on the surface by more than 80% in three out of four bacteria tested: E. coil; P. aeruginosa; and K. pneumoniae. However, no reduction in the bacterium S. aureus was observed. In another study also using silver-coated pins, it was found that the reduction of colonization by four out of five different bacteria ranged from 67% to 95% as compared with uncoated pins (Wassail et al., 1997) . With one test organism, S. haemolyticus, more bacterial cells adhered onto the silver-coated than onto the uncoated pins, presumably because of the unique cell-surface characteristics of this species (Wassail et al., 1997) . After the pins were treated in human serum, similar patterns of bacterial adhesion were observed for both silver-coated and uncoated pins (Wassail et al., 1997) . In an in vivo study where 12 uncoated and 36 Walls binding. After exposure to body fluids, a medical device surface is in contact with the ions in body fluids. Negatively charged antibiotics on the surface are exchanged with anions in body fluids and are released slowly from the device surface. The release of antibiotics provides a high antibiotic concentration near the device surface, exceeding the amount that could be achieved by systemic administration to effectively kill the bacteria proximal to the medical device (Kamal et al., 1991) .
An in vivo comparison study of polyethylene catheters, which were untreated, treated by being soaked in either penicillin or TDMAC solution, or treated with TDMAC-bonded penicillin, was performed using rats (Trooskin et al., 1985) . The catheters were placed in a jugular vein of each rat and positioned in the right atrium. Before closure, the exit site was inoculated with 108 CFU of S. aureus. Five days after inoculation, the catheters were removed, and the tips of catheters were cultured. High rates of catheter colonization, 60 to 80%, were found on the catheters that were either untreated or treated only by penicillin or TDMAC soaking. On the contrary, catheters with TDMACbonded penicillin did not show any colony formation (Trooskin et al., 1985) .
Antibiotic susceptibility was studied and it was found that the combination of rifampin and minocycline was more effective in preventing the colonization of catheter surfaces than any other antibiotic or antibiotic combination tested (Raad et al., 1996) . Treated surfaces displayed a broad-spectrum of inhibitory activity against major catheter-related organisms such as S. epidermidis, S. aureus, and E. faecalis. Clinical trials indicated that central venous catheters with TDMAC-bonded rifampin and minocycline on the surface had reduced the incidence of catheter-related bacterium and the infection rate (Raad et al., 1997) .
TDMAC molecules are also shown to retain the neutral antibiotic vancomycin and proteins such as the tissue plasminogen activator on plastics, probably through the hydrophobic interaction (Harvey) at al., 1989.
An aminoglycoside antibiotic, dibekacin sulfate (DBK) , was bonded to the surface of urethral catheters via ionic bonds, and the prepared catheters were shown in vitro to provide a sustained release of DBK for more than 25 days (Sakamoto et al., 1985) .
2-3. Entrapment
Entrapment of anti-infective agents in a polymermatrix applied on device surfaces has shown promising results in vitro, in vivo, and in clinical studies.
Polymer matrices can be formed either by in situ cross-linking of prepolymers or applying non-reactive polymer coatings. Application of non-reactive polymer matrices is widely used for indwelling medical devices and shows advantages of desired effectiveness and in the duration of protection. Polymer matrices with anti-infective agents could be used directly to construct a device or applied as a thin layer of coating on the medical device surface.
The manufacture of medical devices from antiinfective polymers presents problems in regards to selecting the anti-infective agents and matrix polymers as well as finding suitable processes of medical device construction, and has been more technically challenging than applying coating technology on device surfaces. A cuff, used as an attachment to a central venous catheter to block the potential bacterial entrance, was made of a biodegradable polymer, collagen, impregnated with silver. As the polymer slowly degrades during implantation, the impregnated silver is released to protect the catheter from bacterial invasion. A randomized, multi-center trial showed that the cuff attachment assisted the reduction of catheterrelated infections (Maki et al., 1988) .
The technology of non-reactive polymer coatings uses a coating liquid composed of specific polymers, anti-infective agents, and solvents. After a coating liquid is applied on a medical device surface, solvents are allowed to evaporate, leaving a thin film consisting of the polymers with a uniformly dispersed antiinfective agent. The thin film of polymer acts as a reservoir for a sustained release of anti-infective agents over an appropriate period at an effective concentration. Anti-infective agents in the matrices are not chemically bonded to the matrix polymers, however their activity still remains unaltered. After release from the matrix, the anti-infective agents can act immediately in a predictable manner in their biological effect: absorption, distribution, metabolism, and excretion.
The performance of prepared anti-infective coatings is influenced by the characteristics of both the anti-infective agents and the polymer matrix. Microbiological and physiochemical properties of both the anti-infective agent and polymer should be considered when selecting an anti-infective system. First, the choice of anti-infective agents should depend on the application of a device in order to be effective against the major microorganisms that cause infections on a particular device. The anti-infective agents must also keep their potency when entrapped in the polymer matrix. Broad-spectrum anti-infective agents with strong antibacterial effectiveness and low toxicity are preferred.
However, some clinical complications of the selected agents can only be found when a product is actually used in patients. An example is that after a number of years of application, hypersensitivity reactions to silver sulfadiazine chlorhexidine-coated central venous catheters were reported here in Japan (USFDA, 1998) . The loading of the anti-infective agents will influence the duration of the activity, the efficacy, and the toxicity of the coating. The solubility of a specific agent, the susceptibility of the targeted microorganisms, and its affinity to surrounding tissue all affect the performance of the coating. In addition, the hydrophilicity as well as the chemical structure of the polymer matrix play an important role in the performance of the coating. The elution rate of a given anti-infective agent is dominated by the polymer matrix in which the anti-infective agent is incorporated. The polymers for the matrices must be compatible with the substrates to which the coating is applied, as well as with the selected agent, and must not induce chemical reactions which might alter the chemical structure and potency of the anti-infective agent.
Although there is no chemical bonding between the matrix polymer and the molecules of anti-infective agent using entrapping method, intermolecular interactions exist in non-reactive polymer coatings. Dipole-dipole interactions and van der Waals forces are the intermolecular interactions involved in the system. Dipole-dipole interactions are the attraction between polar molecules, and the forces between molecules of non-polar compounds are van der Waals forces. Hydrogen bonding (RH---HR') is an especially strong kind of dipole-dipole interaction that may be important in interactions after the device is placed in the body. A stronger interaction to a particular agent and a weaker interaction to others may be seen with some polymers. The difference in strength of intermolecular forces could be reflected in the release profile of the system. Silver sulfadiazine and chlorhexidine in a polyurethane matrix applied to central venous catheters have been commercially available in past. In vitro and in vivo studies show that the coated catheters reduce the quantitative level and frequency of bacterial colonization (Bach et al., 1993) . The rate of clinical infections was significantly reduced (Maki et al., 1997) . A meta-analysis of published clinical studies comparing the silver sulfadiazine-and chlorhexidine-coated versus non-coated central venous catheters indicated that the coated catheters were effective in reducing catheter-related bloodstream infection by 40% in patients (Veenstra et al., 1999) .
The water solubility and diffusivity of anti-infective agents through polymer materials determine the 2-4. Application of anti-infective coatings 2-4-1. Antibiotic-resistant bacteria The appearance rate of antibiotic-resistant bacteria is accelerating and is currently a great concern to the medical community. It is unclear how the release of antibiotics from the surfaces of the medical devices. It may contribute to the resistance of bacteria to antibiotics because the technology is new and little data is available. However, it still is an issue of concern in regard to using an antibiotic as an anti-infective agent in preventing device-related infections. Its contribution to the development of antibiotic-resistant bacteria may be too small to be noticed because usually only a small amount of antibiotics is loaded onto each device compared to the amount delivered by systemic administration.
Using combinations of antibiotics and antimicrobials or antimicrobials alone in the coating might address the increasing concern of antibiotic-resistant bacteria efficiently, as there are few, if any, bacteria that have developed strains resistant to antimicrobials. Nevertheless, further investigation on antibiotic resistance is necessary to examine the impact from antibiotic-impregnated devices.
2-4-2. Leaching of anti-infective agents from medical device
There are two alternative approaches concerning surface treatments for indwelling medical devices that protect patients from device-related infections. One approach focuses on the technologies that provide the devices with a surface from which antimicrobials and/or antibiotics leach out to inhibit bacterial growth on and near the device surface. The other approach focuses on non-leachable technologies, by which bacteria are killed when they come into contact with a surface containing the tightly bound anti-infective agents. So far, neither way can definitively prevent the incidence of device-related infections.
Schierholz et al (Schierholz et al., 1994 ) studied the bacterial adhesion to the antibiotic-loaded silicone shunt and the kinetics involved in killing the bacteria. They concluded from the results that an antibiotic release exceeding the minimal bactericidal concentration in the environment of the implant over a long period is a prerequisite for effectively preventing bacterial colonization. Only devices with this spectrum of anti-infective properties are able to kill metabolic non-active subpopulations of adherent microorganisms and can prevent the bacterial colonization on polymeric device surfaces. Some antimicrobial-treated indwelling medical devices that show evidence of reducing the clinical incidence of bacterium on device surfaces have leachable surfaces. The examples are central venous catheters with antimicrobials (silver sulfadiazine and chlorhexidine), central venous catheters with an antibiotics (rifampin and minocycline), and Swan pulmonary-artery catheters with antimicrobial (benzalkonium).
Anti-infective agents released from devices will kill bacteria that not only are in direct contact with, but also float nearby, the surface. Although there is a sufficient amount of anti-infective agent released, devices usually do not exhibit observable signs of toxicity in the biocompatibility tests because the system is usually sophisticatedly designed: the dosage of anti-infective agent on each device is small, and the release is sustained. Typical loading of antiinfective agents per device (i.e., catheters) is in the milligram range, which is far less than a typical, systemically administered dosage. In addition, the small dosage is released over a period of time: as the agent diffuses from the vicinity of the device, it mixes with body fluids, which markedly decreases its concentration. The circulating levels of the agents are usually negligible, and the toxic potential from the agents is diminished.
On the other hand, products obtained by a surface treatment involving far less leaching, such as Foley catheters coated with a silver-oxide-silicone coating, showed poorer performance. The explanation for such a poor performance may be the following: after the devices are indwelled, their surfaces will encounter all species, such as bacteria, proteins, and salts, existing in the tissues and body fluids in direct contact. Layers of physiological deposition, which could be nutrients to bacteria, can be formed on the device surface quickly after the indwelling (Winters et al., 1995) . Even dead bacteria that are killed by contact with the fresh anti-infective device could remain on the surface and shield newly entering bacteria from coming into contact with and being killed by the antiinfective surface (Morris et al., 1997) . After the formation of physiological layers of deposition, the antiinfective activity on the surface will be partially deactivated, and the device may no longer be antiinfective if the agents are over-tightly bound to the surface.
The application of a non-leachable anti-infective surface may be well suited to cases where there is no biological deposition forming on the surface, or where a device is constructed in such a way that a thin layer of deposition will not shield its anti-infective activity, such as by use of long enough spacers between the surface and the anti-infective sites.
CONCLUSION
Discovery of anti-infective agents and biomaterials with long-lasting, highly active anti-infective properties to be used as surface treatment materials or to construct medical devices will add significant advantages when designing and developing indwelling medical devices that prevent device-related infections. Manufacturing processes which assure the production of uniform surfaces with desired porosity need to be improved. Successful manufacturing of medical devices with anti-infective surfaces that provide sustained resistance to bacterial adherence, enhance healthy tissue integration, and improve compatibility with host defense mechanisms will result in the prevention of medical device-related infections, thereby improving health care.
Anti-infective agent-impregnated medical devices have recently shown promising results in reducing device-related infections. However, in some applications the anti-infective activity still diminishes or disappears more quickly than desired after the device surfaces come into contact with body fluids or tissues, and bacterial colonization is still found on those devices. This may be due to either incorporating an insufficient amount of the anti-infective agent or binding the anti-infective agent too tightly to the coating to be effectively released. Optimization of the dosage and release rate of an anti-infective agent in the polymer matrix is certainly an important task. 
